CIK 0002022416 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Silexion Therapeutics Corp
Sign in to watch- Ticker
- SLXN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 972-8-6286005
- Business address
- 12 ABBA HILLEL ROAD, RAMAT GAN, Israel, 5250606
- Former names
- Biomotion Sciences
Securities
- SLXN Ordinary Shares Nasdaq
- SLXNW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-09 | Abramov Dror Yosef Director | Grant or award | +794 | 794 | ||
| 2025-02-09 | Abramov Dror Yosef Director | Grant or award · Stock Option (right to buy ordinary shares) | +935 | 935 | ||
| 2025-02-09 | Alon Ruth Director | Grant or award | +794 | 794 | ||
| 2025-02-09 | Alon Ruth Director | Grant or award · Stock Option (right to buy ordinary shares) | +935 | 935 | ||
| 2025-02-09 | Noy Shlomo Director | Grant or award | +1,587 | 1,587 | ||
| 2025-02-09 | Noy Shlomo Director | Grant or award · Stock Option (right to buy ordinary shares) | +1,872 | 1,872 | ||
| 2025-02-09 | Lushi Avner Director | Grant or award | +1,587 | 1,587 | ||
| 2025-02-09 | Lushi Avner Director | Grant or award · Stock Option (right to buy ordinary shares) | +1,872 | 1,872 | ||
| 2025-02-09 | Peled Amnon Director | Grant or award | +661 | 661 | ||
| 2025-02-09 | Peled Amnon Director | Grant or award · Stock Option (right to buy Ordinary Shares) | +780 | 780 |
Page 2 of 2 · 30 trades